Clinical Pearls for the Care of Patients with CLL

ASCO 2020 Virtual Meeting/May 29-31, 2020
EHA 2020 Virtual Meeting/June 11-21, 2020
Highlights in CLL treatment from CCO’s coverage of ASCO 2020 and EHA 2020, selected by our expert faculty.
John Allan, MD
Jennifer R. Brown, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 250 KB
Released: August 28, 2020

Acknowledgements

Supported by an educational grant from
AstraZeneca

Related Content

Download this slideset to review the latest clinical data informing optimal management strategies for follicular lymphoma

Emily Bucholtz Headshot Emily Bucholtz, RPh Nichole Fisher Headshot Nichole Fisher, RN, BSN Jeff P. Sharman, MD Released: October 14, 2020

Download this ExpressPoints slideset for a quick summary of the latest clinical data informing optimal management of follicular lymphoma

Emily Bucholtz Headshot Emily Bucholtz, RPh Nichole Fisher Headshot Nichole Fisher, RN, BSN Jeff P. Sharman, MD Released: October 14, 2020

Expert insight commentary from Clinical Care Options (CCO) on use of luspatercept for the treatment of anemia in myelodysplastic syndromes (MDS) patients

Guillermo Garcia-Manero, MD Released: October 14, 2020

Watch a short video providing an expert view on treatment options after BTK inhibitor– and venetoclax for patients with CLL from Clinical Care Options (CCO)

Jeff P. Sharman, MD
Program Director
Jeremy S. Abramson, MD, MMSc
Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: October 14, 2020 Expired: October 13, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue